NZ598749A - Fused heterocyclic ring derivative and use thereof - Google Patents

Fused heterocyclic ring derivative and use thereof

Info

Publication number
NZ598749A
NZ598749A NZ598749A NZ59874910A NZ598749A NZ 598749 A NZ598749 A NZ 598749A NZ 598749 A NZ598749 A NZ 598749A NZ 59874910 A NZ59874910 A NZ 59874910A NZ 598749 A NZ598749 A NZ 598749A
Authority
NZ
New Zealand
Prior art keywords
heterocyclic ring
fused heterocyclic
ring derivative
compounds
useful
Prior art date
Application number
NZ598749A
Other languages
English (en)
Inventor
Satoshi Sasaki
Yuta Tanaka
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43627972&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ598749(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NZ598749A publication Critical patent/NZ598749A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NZ598749A 2009-08-26 2010-08-25 Fused heterocyclic ring derivative and use thereof NZ598749A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009195770 2009-08-26
JP2010015644 2010-01-27
PCT/JP2010/064413 WO2011024872A1 (ja) 2009-08-26 2010-08-25 縮合複素環誘導体およびその用途

Publications (1)

Publication Number Publication Date
NZ598749A true NZ598749A (en) 2013-01-25

Family

ID=43627972

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ598749A NZ598749A (en) 2009-08-26 2010-08-25 Fused heterocyclic ring derivative and use thereof

Country Status (24)

Country Link
US (1) US8907089B2 (enExample)
EP (1) EP2471790B1 (enExample)
JP (1) JP5599802B2 (enExample)
KR (1) KR20120078703A (enExample)
CN (1) CN102574851A (enExample)
AU (1) AU2010287492A1 (enExample)
BR (1) BR112012004134A2 (enExample)
CA (1) CA2771833A1 (enExample)
CL (1) CL2012000461A1 (enExample)
CR (1) CR20120095A (enExample)
DO (1) DOP2012000048A (enExample)
EA (1) EA201270311A1 (enExample)
EC (1) ECSP12011747A (enExample)
GE (1) GEP20146075B (enExample)
IL (1) IL218323A0 (enExample)
IN (1) IN2012DN02069A (enExample)
MA (1) MA33589B1 (enExample)
MX (1) MX2012002419A (enExample)
NZ (1) NZ598749A (enExample)
PE (1) PE20121326A1 (enExample)
SG (1) SG178504A1 (enExample)
TN (1) TN2012000084A1 (enExample)
WO (1) WO2011024872A1 (enExample)
ZA (1) ZA201201795B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2471793B1 (en) * 2009-08-26 2016-10-05 Takeda Pharmaceutical Company Limited Fused heterocyclic ring derivative and use thereof
WO2014140077A1 (en) * 2013-03-14 2014-09-18 Glaxosmithkline Intellectual Property (No.2) Limited Furopyridines as bromodomain inhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436965B1 (en) 2000-03-02 2002-08-20 Merck Frosst Canada & Co. PDE IV inhibiting amides, compositions and methods of treatment
EP1310488A4 (en) 2000-08-09 2005-08-10 Mitsubishi Pharma Corp CONDENSED BICYCLIC AMIDE COMPOUNDS AND MEDICAL USES THEREOF
CA2469435A1 (en) 2001-12-21 2003-07-24 X-Ceptor Therapeutics, Inc. Modulators of lxr
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
AU2003265853A1 (en) 2002-08-29 2004-03-19 Curis, Inc. Hedgehog antagonists, methods and uses related thereto
WO2005033288A2 (en) * 2003-09-29 2005-04-14 The Johns Hopkins University Hedgehog pathway antagonists
US20050203081A1 (en) 2004-02-25 2005-09-15 Jinbo Lee Inhibitors of protein tyrosine phosphatase 1B
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
WO2008057469A1 (en) * 2006-11-02 2008-05-15 Wyeth Small organic molecule regulators of cell proliferation
US8273747B2 (en) 2006-11-02 2012-09-25 Curis, Inc. Small organic molecule regulators of cell proliferation
LT2170860T (lt) 2007-06-29 2017-01-10 Pfizer Inc. Benzimidazolo dariniai
RU2364597C1 (ru) 2007-12-14 2009-08-20 Андрей Александрович Иващенко ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
JP4685891B2 (ja) 2008-02-19 2011-05-18 株式会社ハネックス 分離装置
JO3259B1 (ar) 2008-02-26 2018-09-16 Takeda Pharmaceuticals Co مشتق دائري مغاير ملتحم واستخدامه
JP2010015644A (ja) 2008-07-04 2010-01-21 Fujitsu Ltd スピンドル機構、電磁変換特性評価機、および情報記憶装置
GB0900484D0 (en) 2009-01-13 2009-02-11 Angeletti P Ist Richerche Bio Therapeutic agent

Also Published As

Publication number Publication date
AU2010287492A1 (en) 2012-03-29
IL218323A0 (en) 2012-04-30
CA2771833A1 (en) 2011-03-03
GEP20146075B (en) 2014-04-10
KR20120078703A (ko) 2012-07-10
SG178504A1 (en) 2012-04-27
JP5599802B2 (ja) 2014-10-01
TN2012000084A1 (en) 2013-09-19
ECSP12011747A (es) 2012-05-30
ZA201201795B (en) 2013-05-29
DOP2012000048A (es) 2012-05-15
EA201270311A1 (ru) 2012-09-28
PE20121326A1 (es) 2012-10-11
JPWO2011024872A1 (ja) 2013-01-31
MA33589B1 (fr) 2012-09-01
WO2011024872A1 (ja) 2011-03-03
CN102574851A (zh) 2012-07-11
EP2471790A1 (en) 2012-07-04
IN2012DN02069A (enExample) 2015-08-21
BR112012004134A2 (pt) 2017-06-20
EP2471790A4 (en) 2013-07-31
CL2012000461A1 (es) 2012-10-05
US8907089B2 (en) 2014-12-09
EP2471790B1 (en) 2015-03-18
CR20120095A (es) 2012-06-26
MX2012002419A (es) 2012-04-19
US20120220570A1 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
MX2015001207A (es) Compuestos de heteroarilo y heterociclo novedosos, composición y métodos de los mismos.
NZ577916A (en) Cyclopamine analogs
MX347917B (es) Compuestos a base de imidazo[1,2-b]piridazina, composiciones que los comprenden, y metodos para su uso.
GEP201606560B (en) Macrocyclic derivatives for the treatment of proliferative diseases
MX2009006706A (es) Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
NZ749557A (en) 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1h)-one derivatives as fungicides
MX358682B (es) Derivados de pirazolo [1,5a]pirimidina y de tieno[3,2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4).
EA201101180A1 (ru) Производные триазоло[4,3-в]пиридазина и их применение для рака предстательной железы
NZ596571A (en) Pyrazolopyrimidines and related heterocycles as kinase inhibitors
MX2009010059A (es) Derivados de quinolina para el tratamiento de enfermedades inflamatorias.
NZ604708A (en) Macrocyclic compounds as trk kinase inhibitors
MY156727A (en) N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
NZ597517A (en) 5-fluoropyrimidinone derivatives
NZ703111A (en) Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
MX2010008040A (es) Derivados de pirimidina 5-fluoro como fungicidas.
PE20090506A1 (es) DERIVADOS DE IMIDAZO-[1,2-b]-PIRIDAZIN COMO INHIBIDORES DE ALK5 Y/O ALK4
TNSN08283A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
IN2012DN00692A (enExample)
IL215074A0 (en) Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
TNSN08227A1 (en) [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases.
WO2009023402A3 (en) Heterocyclic compounds and uses as anticancer agents
MX362215B (es) Derivados 2-aminopirido-[4,3-d]pirimidin-5-ona y su uso como inhibidores de wee-1.
NZ627361A (en) 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors
MX2012013274A (es) Novedosos derivados de la pirimidina.
MX2012001623A (es) Derivados de 5-fluoro-2-oxopirimidina-1 (2h)-carboxilato.

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE POSTPONEMENT PERIOD HAS BEEN CORRECTED TO 0

Effective date: 20130122

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 25 AUG 2017 BY CPA GLOBAL

Effective date: 20140710

LAPS Patent lapsed